Houlihan Lokey Advises RevHealth

Houlihan Lokey is pleased to announce that RevHealth, LLC, a science-focused independent provider of omnichannel healthcare communications, supporting pharma, biotech, device, and other healthcare clients with professional promotion, medical education, and patient education and advocacy communication services, has been recapitalized by WindRose Health Investors, LLC (WindRose). The transaction closed on July 22, 2022.

Founded in 2006 and based in Morristown, New Jersey, RevHealth is one of the largest independent providers of omnichannel healthcare communications to the life sciences industry.

With WindRose’s investment, RevHealth will be able to further accelerate its impressive growth, drawing on WindRose’s extensive experience investing in innovative pharmaceutical services companies. Bruce Epstein, Bruce Medd, and Brian Wheeler, RevHealth’s founders, will continue to lead the company and remain significant shareholders.

WindRose makes equity investments in companies that operate within the services sectors of the healthcare industry. The firm focuses on companies with profitable business models and demonstrated abilities to deliver cost-effective solutions. WindRose manages more than $2.6 billion in investments. WindRose is based in New York City and invests in companies throughout the United States.

Houlihan Lokey served as the exclusive financial advisor to RevHealth. This deal highlights Houlihan Lokey’s leading experience in the pharma services space and represents the firm’s 18th transaction in this sector since 2019.